CHICAGO (Reuters) - Women who took a commonly prescribed hormone replacement therapy pill had double the risk of developing benign proliferative breast disease, which may raise the risk of breast cancer, U.S. researchers said on Tuesday. The study, published in the Journal of the National Cancer Institute, is one of dozens trying to paint a clearer picture of what risks might come from taking hormone replacement therapy, or HRT, to treat menopause symptoms.
